Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer. - Wikidata - awgldk - TriplyDB

Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer.

Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer.

http://www.wikidata.org/entity/Q33318574

about

Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis FOXM1 confers acquired cisplatin resistance in breast cancer cells The Role of Forkhead Box Protein M1 in Breast Cancer Progression and Resistance to Therapy Prognostic Value of FOXM1 in Patients with Malignant Solid Tumor: A Meta-Analysis and System Review Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications Unsupervised feature construction and knowledge extraction from genome-wide assays of breast cancer with denoising autoencoders Integrating Multi-omics Data to Dissect Mechanisms of DNA repair Dysregulation in Breast Cancer Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.Forkhead box M1 transcription factor: a novel target for cancer therapy.Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis.Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression.FoxM1 mediates resistance to herceptin and paclitaxel.FoxM1 is a novel target of a natural agent in pancreatic cancer.Down-regulation of FoxM1 by thiostrepton or small interfering RNA inhibits proliferation, transformation ability and angiogenesis, and induces apoptosis of nasopharyngeal carcinoma cells.MicroRNA-194 inhibits the epithelial-mesenchymal transition in gastric cancer cells by targeting FoxM1.Overexpression of FOXM1 is associated with metastases of nasopharyngeal carcinoma Identification of early molecular markers for breast cancer.Proteasome inhibitors in cancer therapy Insulin-like growth factor-1 receptor signaling increases the invasive potential of human epidermal growth factor receptor 2-overexpressing breast cancer cells via Src-focal adhesion kinase and forkhead box protein M1.Resistance to HER2-targeted therapies: a potential role for FOXM1.Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells.The 26S proteasome complex: an attractive target for cancer therapy FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.Nucleophosmin interacts with FOXM1 and modulates the level and localization of FOXM1 in human cancer cells.Investigation of FOXM1 as a Potential New Target for Melanoma.FOXM1 is overexpressed in B-acute lymphoblastic leukemia (B-ALL) and its inhibition sensitizes B-ALL cells to chemotherapeutic drugs FoxM1 regulates mammary luminal cell fate The critical role of dysregulated FOXM1-PLAUR signaling in human colon cancer progression and metastasis.MEK inhibition increases lapatinib sensitivity via modulation of FOXM1 Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells.p28, a first in class peptide inhibitor of cop1 binding to p53.Identification of potential therapeutic targets in malignant mesothelioma using cell-cycle gene expression analysis Hedgehog signalling in breast cancer.Down-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells.3,3'-Diindolylmethane enhances taxotere-induced growth inhibition of breast cancer cells through downregulation of FoxM1.Prognostic discrimination using a 70-gene signature among patients with estrogen receptor-positive breast cancer and an intermediate 21-gene recurrence score.A conserved phosphorylation site within the forkhead domain of FoxM1B is required for its activation by cyclin-CDK1.ErbB2, FoxM1 and 14-3-3ζ prime breast cancer cells for invasion in response to ionizing radiation.A new target for proteasome inhibitors: FoxM1

P2860

Q24613046-3F6AA3CB-7DEF-46B6-ABB7-253F24A86415 Q24642596-2E950515-12D0-48B5-8209-FA2ACEFC5C31 Q26768290-F8F2D178-63A4-43CD-B63C-B28E58F015B8 Q26785676-084D6E0C-894A-4EA3-BB1D-191E054A9D69 Q28076697-6C21A51A-476A-4D67-9C97-500C0E463DCF Q30616727-ADC071D2-35AF-488D-BE7E-B62D5C08AB55 Q31132980-29ECD159-975E-4C4A-B23E-FBC68BA9872F Q33670486-A73EB238-F247-4395-9CF1-8CBCD17A822E Q33729250-4F49280E-A558-4B33-A687-1888F248B2A1 Q33762091-F2DB3601-31A7-4E00-A9D3-07C985DA5BEE Q33864523-61D56881-6324-4A18-B252-42A203FF82C5 Q33946664-851907AE-BC0A-42ED-B0D6-57AFCD8227D0 Q34286063-BF7DA1AC-4BA9-4151-AAF2-B2B1881A0CB4 Q34371119-5529FD97-AA3B-4DD0-A6D0-AEE61CB20AF1 Q34416069-AC6658D5-49E1-47FD-B225-7A613AB4E4BD Q34589178-E4A6BC53-F482-4B09-AE7C-34DAE7947C3B Q34608080-0F023AE1-E5C0-4B65-8C66-81E0272720CE Q34939959-FB2C71D5-4519-4213-8333-DBCB3A21D264 Q34946846-BE862ED3-8A20-4FC0-AF38-C62EBC961FA3 Q34955355-11BD1463-E859-4A33-9AD0-549A70103421 Q35163008-0113BFC1-F490-4A16-8379-C27F226B50B4 Q35624079-2A4EE493-1DE3-43E9-B9D3-A1E255C4FC03 Q35793788-DFB22184-8B84-4685-B961-A15A39ED1884 Q35800767-8A6E4D24-FA23-4DAF-87BC-8A07D96DD156 Q35842155-C7D911D6-8E39-477F-B2D6-CDE455C5AB6C Q35861978-896B5E57-8E8C-440D-A636-F48829F6226C Q36094104-A09B42D9-AD40-4C3A-83E1-EECD4E8990B5 Q36106731-762089DA-3B4E-4B96-9E87-70A55F9F9A88 Q36510909-56F93280-7DF0-4747-8548-4E36FD55C1CB Q36833298-B23EF451-7F15-4F8C-9EBF-568702E2AC5E Q36872440-2DAF3436-088D-4B96-9B3E-B78EED396B5A Q36959166-A8C6FACF-9FBD-40AF-9B6A-91DA768718FC Q37150740-014EF2CA-686A-4461-B04C-ADBB3C8825EB Q37214195-EC4617F8-C044-407E-B48B-959F14148E87 Q37220370-BE901C75-CC06-47EA-837C-0ECC39D3327E Q37243057-E18D15E6-0115-4CEE-BF28-81A59A177E9A Q37420876-03F45857-8E09-45B8-8317-EE561DB25F8D Q37431862-A03F57A6-C369-4FC3-A270-AFE15F336167 Q37663938-95E90696-E1E1-4B15-858D-5164850CF962 Q37674617-62BDCB93-E7A0-4113-BEE4-183E7D16C9EC

P2860

Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer.

http://www.wikidata.org/entity/Q33318574

description

2008 nî lūn-bûn

@nan

2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Tight correlation between expr ...... d HER2 in human breast cancer.

@ast

Tight correlation between expr ...... d HER2 in human breast cancer.

@en

Tight correlation between expr ...... d HER2 in human breast cancer.

@nl

type

label

Tight correlation between expr ...... d HER2 in human breast cancer.

@ast

Tight correlation between expr ...... d HER2 in human breast cancer.

@en

Tight correlation between expr ...... d HER2 in human breast cancer.

@nl

prefLabel

Tight correlation between expr ...... d HER2 in human breast cancer.

@ast

Tight correlation between expr ...... d HER2 in human breast cancer.

@en

Tight correlation between expr ...... d HER2 in human breast cancer.

@nl

P1433

Q33318574-51496C3D-CD5B-45C9-ACD0-8124B049AC1C

P1476

Q33318574-90DCD786-1F6C-4671-B9E4-E38EBAFB14C5

P2093

Q33318574-1E7622E7-ADEE-4393-8169-35AFFF0D3959

Q33318574-8437E2FA-3850-43B8-A291-F3AA13367478

Q33318574-B6618533-014E-418F-B105-D8493D0E4489

Q33318574-DDB4666F-4670-4A9D-AE89-4B6A26D8D4CC

Q33318574-E7D1C338-D94F-4BBF-BD01-246D9C38201D

P2860

Q33318574-1E40267D-1D6F-4F10-8A89-4BAAA107CEA1

Q33318574-29080F9C-5AA3-4352-8396-8FF57FA86A8F

Q33318574-2C09FD96-4290-4DBA-9770-A4E3F9D876C6

Q33318574-3A7C6BBD-A2B8-493F-A933-0943814F362A

Q33318574-3CB41B97-CDF1-4DF0-B764-4CB759B305C3

Q33318574-3E422C45-9AA1-4B61-BE52-6DB0180D5504

Q33318574-40CC6DFD-5884-41F7-84BF-4FDE60DC2B38

Q33318574-477654FE-A008-4654-9D5C-18F5391F40E3

Q33318574-558905D9-EEC1-4DC0-8C8F-FCF06A00BE2A

Q33318574-5DD3B8B4-C8FD-4DFB-BFEF-CFD29C906C22

P2888

Q33318574-23A85484-3665-4129-B0B7-6C968DC3B1B9

P304

Q33318574-36FE8E45-AA0E-4E51-84C5-A6D30274CF15

P31

Q33318574-E9962B61-3B62-4350-A8EE-108B605C0C10

P356

Q33318574-F2395F3E-6E65-4F34-A837-498E2FA31FB9

P407

Q33318574-D8ED96D8-6F7A-415C-B1A6-41392B9CD0F2

P478

Q33318574-08217486-24EF-44A6-810F-C841FC78942C

P50

Q33318574-6E2EBA17-B627-41B5-9972-116674F0A4AD

Q33318574-B99C1325-5689-466C-BFB4-141A6600A135

Q33318574-D8A17E70-D2E8-435E-8C41-1BAD1ED63620

P577

Q33318574-EEC9C989-B586-487C-9F42-E5F7A8F6C827

P5875

Q33318574-B7DB2A7E-5CF9-457D-A481-E1E4AD41940F

P6179

Q33318574-4AFD3DBB-19E1-4D0B-BFDE-259D167567AC

P698

Q33318574-17E3A824-A3EC-4856-9C23-FB045759B1D6

P932

Q33318574-98EE5EA7-0627-4322-851F-FC6E8A4D91B3

P356

P1433

P1476

Tight correlation between expr ...... d HER2 in human breast cancer.

@en

P2093

Anette ten Haaf

http://www.w3.org/2001/XMLSchema#string

Arndt Hartmann

http://www.w3.org/2001/XMLSchema#string

Edgar Dahl

http://www.w3.org/2001/XMLSchema#string

Nuran Bektas

http://www.w3.org/2001/XMLSchema#string

Peter Johannes Wild

http://www.w3.org/2001/XMLSchema#string

P2860

The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells

Molecular analysis of a novel winged helix protein, WIN. Expression pattern, DNA binding property, and alternative splicing within the DNA binding domain

Unified nomenclature for the winged helix/forkhead transcription factors

The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy

Cell death by mitotic catastrophe: a molecular definition

Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe

Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis

Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer

Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicity

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

P2888

P304

42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-8-42

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Ruth Knüchel-Clarke

Juliane Lüscher-Firzlaff

P577

2008-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5597144

http://www.w3.org/2001/XMLSchema#string

P6179

1030346880

http://www.w3.org/2001/XMLSchema#string

P698

18254960

http://www.w3.org/2001/XMLSchema#string

P932

2265720

http://www.w3.org/2001/XMLSchema#string